Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Merrouche

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapyA Madroszyk, J Egreteau, L Martin, et al.
Presse Medicale (Paris, France : 1983)|September 10, 1988
[Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases]L Guillevin, Y Merrouche, M Gayraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2014
Is oral chemotherapy prescription safe for patients? A cross-sectional surveyA Bourmaud, C Pacaut, A Melis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapyY Merrouche, G Catimel, P Rebattu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of interleukin-2-induced thrombocytopenia by intravenous immunoglobulinV Cottin, S Négrier, J Y Ranchère, et al.
Lancet (London, England)|September 5, 1987
Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) yearsF Boussin, D Dormont, Y Merrouche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumorsM Marty, P Fumoleau, A Adenis, et al.
American Journal of Clinical Oncology|February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primaryE Voog, Y Merrouche, V Trillet-Lenoir, et al.
British Journal of Cancer|May 18, 2001
Carcinoma of the colonA Adenis, T Conroy, P Lasser, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinomaC Lasset, Y Merrouche, S Negrier, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapyA Madroszyk, J Egreteau, L Martin, et al.
Presse Medicale (Paris, France : 1983)|September 10, 1988
[Periarteritis nodosa related to hepatitis B virus. Determination of a new therapeutic strategy: 13 cases]L Guillevin, Y Merrouche, M Gayraud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2014
Is oral chemotherapy prescription safe for patients? A cross-sectional surveyA Bourmaud, C Pacaut, A Melis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
A phase I antiemetic study of MDL 73,147EF, a novel 5-hydroxytryptamine antagonist in cancer patients receiving emetogenic chemotherapyY Merrouche, G Catimel, P Rebattu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of interleukin-2-induced thrombocytopenia by intravenous immunoglobulinV Cottin, S Négrier, J Y Ranchère, et al.
Lancet (London, England)|September 5, 1987
Possible involvement of HIV in neuropsychiatric episode in patient seronegative for two (or more) yearsF Boussin, D Dormont, Y Merrouche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumorsM Marty, P Fumoleau, A Adenis, et al.
American Journal of Clinical Oncology|February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primaryE Voog, Y Merrouche, V Trillet-Lenoir, et al.
British Journal of Cancer|May 18, 2001
Carcinoma of the colonA Adenis, T Conroy, P Lasser, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinomaC Lasset, Y Merrouche, S Negrier, et al.
Pageof 6